COVID-19

Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study

Jose María Álvaro Gracia, Carlos Sanchez-Piedra, Javier Manero, María Ester Ruiz-Lucea, Laura López-Vives, Cristina Bohorquez, Julia Martinez-Barrio, Gema Bonilla, Paloma Vela, María Jesús García-Villanueva, María Teresa Navío-Marco, Marina Pavía, María Galindo, Celia Erausquin, Miguel A Gonzalez-Gay, Inigo Rua-Figueroa, Jose M Pego-Reigosa, Isabel Castrejon, Jesús T Sanchez-Costa, Enrique González-Dávila, Federico Diaz-Gonzalez

10.1136/rmdopen-2021-001925

December 9, 2021

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Alenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling, The ARTIS Study Group, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d’Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling

10.1136/rmdopen-2021-001987

December 8, 2021